Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Discoidin Domain Receptor 2 (DDR2) is a receptor tyrosine kinase activated by fibrillar collagens (types I, III, X). It plays a crucial role in cell-matrix interactions, influencing cell differentiation, ECM remodeling, cell migration, and proliferation. Dysregulation of DDR2 is implicated in diseases like fibrosis, arthritis, and cancer, making it a potential therapeutic target.
Inhibition of DDR2 kinase activity to block downstream signaling pathways involved in cell growth, differentiation, survival, migration, and matrix remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Discoidin Domain Receptor 2 (DDR2).